DIFFERENTIAL DNA ADDUCT FORMATION AND DISAPPEARANCE IN 3 MOUSE-TISSUES AFTER TREATMENT WITH THE MYCOTOXIN OCHRATOXIN-A

被引:133
作者
PFOHLLESZKOWICZ, A
GROSSE, Y
KANE, A
CREPPY, EE
DIRHEIMER, G
机构
[1] UNIV STRASBOURG 1, F-67070 STRASBOURG, FRANCE
[2] INST TECHNOL ALIMENTAIRE, DAKAR, SENEGAMBIA
[3] UNIV BORDEAUX 2, TOXICOL & HYG APPL LAB, F-33076 BORDEAUX, FRANCE
来源
MUTATION RESEARCH | 1993年 / 289卷 / 02期
关键词
OCHRATOXIN-A; DNA ADDUCTS; GENOTOXICITY;
D O I
10.1016/0027-5107(93)90077-S
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Ochratoxin A (OTA) is a mycotoxin which has been implicated in Balkan endemic nephropathy, a disease characterized by a high incidence of urinary tract tumors. It induces DNA single-strand breaks and has been shown to be carcinogenic in two rodent species. For a better understanding of the OTA genotoxic effect, OTA-DNA adduct formation and disappearance has been measured using the P-32-post-labelling method after oral administration of 2.5 mg/kg of OTA to mice. In kidney, liver and spleen, several modified nucleotides were clearly detected in DNA, 24 h after administration of OTA, but their level varied, significantly in a tissue and time dependent manner over a 16-day period. Total DNA adducts reached a maximum at 48 h when 103, 42 and 2.2 adducts per 10(9) nucleotides were found respectively in kidney, liver and spleen, indicating that kidney is the main target of the genotoxicity and likely carcinogenicity of OTA. The major adduct differed between kidney and liver. All adducts disappeared in liver and spleen 5 days after compound administration, whereas some adducts persisted for at least 16 days in the kidney. Some adducts were organ specific. The finding that the adducts are not quantitatively and qualitatively the same in the three organs examined is likely due to differences of metabolism in these organs, leading to different ultimate carcinogens and may also result from differences in the efficiency of repair processes.
引用
收藏
页码:265 / 273
页数:9
相关论文
共 41 条
[1]   VALIDATION AND COMPARATIVE STUDIES ON 180 CHEMICALS WITH S-TYPHIMURIUM STRAINS AND V79 CHINESE-HAMSTER CELLS IN THE PRESENCE OF VARIOUS METABOLIZING SYSTEMS [J].
BARTSCH, H ;
MALAVEILLE, C ;
CAMUS, AM ;
MARTELPLANCHE, G ;
BRUN, G ;
HAUTEFEUILLE, A ;
SABADIE, N ;
BARBIN, A ;
KUROKI, T ;
DREVON, C ;
PICCOLI, C ;
MONTESANO, R .
MUTATION RESEARCH, 1980, 76 (01) :1-50
[2]   EVALUATION OF OCHRATOXIN-A FOR MUTAGENICITY IN A BATTERY OF BACTERIAL AND MAMMALIAN-CELL ASSAYS [J].
BENDELE, AM ;
NEAL, SB ;
OBERLY, TJ ;
THOMPSON, CZ ;
BEWSEY, BJ ;
HILL, LE ;
REXROAT, MA ;
CARLTON, WW ;
PROBST, GS .
FOOD AND CHEMICAL TOXICOLOGY, 1985, 23 (10) :911-918
[3]  
BENDELE AM, 1985, J NATL CANCER I, V75, P735
[4]   GENE SPECIFIC DNA-REPAIR [J].
BOHR, VA .
CARCINOGENESIS, 1991, 12 (11) :1983-1992
[5]  
BOORMAN G, 1989, NIH892813 PUBL
[6]  
CASTEGNARO M, 1987, CANCER RES, V47, P3608
[7]   EPIDEMIOLOGY OF BALKAN ENDEMIC NEPHROPATHY [J].
CEOVIC, S ;
HRABAR, A ;
SARIC, M .
FOOD AND CHEMICAL TOXICOLOGY, 1992, 30 (03) :183-188
[8]   EFFECTS OF SOME MYCOTOXINS ON MITOGEN-INDUCED BLASTOGENESIS AND SCE FREQUENCY IN HUMAN-LYMPHOCYTES [J].
COORAY, R .
FOOD AND CHEMICAL TOXICOLOGY, 1984, 22 (07) :529-534
[9]   GENOTOXICITY OF OCHRATOXIN-A IN MICE - DNA SINGLE-STRAND BREAK EVALUATION IN SPLEEN, LIVER AND KIDNEY [J].
CREPPY, EE ;
KANE, A ;
DIRHEIMER, G ;
LAFARGEFRAYSSINET, C ;
MOUSSET, S ;
FRAYSSINET, C .
TOXICOLOGY LETTERS, 1985, 28 (01) :29-35
[10]   THE MYCOTOXIN OCHRATOXIN-A IS A SUBSTRATE FOR PHENYLALANINE-HYDROXYLASE IN ISOLATED RAT HEPATOCYTES AND INVIVO [J].
CREPPY, EE ;
CHAKOR, K ;
FISHER, MJ ;
DIRHEIMER, G .
ARCHIVES OF TOXICOLOGY, 1990, 64 (04) :279-284